Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.1.94 extracted from

  • Chen, X.; Ying, Z.; Lin, X.; Lin, H.; Wu, J.; Li, M.; Song, L.
    Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells (2013), J. Clin. Invest., 123, 2576-2589.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
diagnostics the enzyme AGK-based mechanism for constitutive activation of JAK2/STAT3 signaling in solid tumors and may represent a prognostic biomarker. AGK overexpression correlates with progression and poor prognosis in human esophageal squamous cell cancer cells Homo sapiens
drug development the enzyme AGK-based mechanism for constitutive activation of JAK2/STAT3 signaling in solid tumors and may represent a therapeutic target Homo sapiens

Cloned(Commentary)

Cloned (Comment) Organism
gene agk, recombinant overexpression of FLAG-tagged AGK in ECa109 and KYSE510 cells Homo sapiens

Protein Variants

Protein Variants Comment Organism
additional information overexpression of AGK sustains constitutive JAK2/STAT3 activation, consequently promoting the cancer stem cell population and augmenting the tumorigenicity of esophageal squamous cell carcinoma cells both in vivo and in vitro. Enzyme knockout by expression of specific RNAi in esophageal squamous cell cancer cells Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens Q53H12 gene agk
-

Source Tissue

Source Tissue Comment Organism Textmining
carcinoma cell
-
Homo sapiens
-
esophageal squamous cell carcinoma cell
-
Homo sapiens
-

Synonyms

Synonyms Comment Organism
AGK
-
Homo sapiens

General Information

General Information Comment Organism
physiological function acylglycerol kinase (AGK) is a multisubstrate lipid kinase, that catalyzes the production of lysophosphatidic acid and phosphatidic acid from monoacylglycerol and diacylglycerol. Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells, the enzyme AGK directly interacts with the JH2 domain to relieve inhibition of JAK2 and activate JAK2/STAT3 signaling. AGK levels significantly correlate with increased STAT3 phosphorylation, poorer disease-free survival, and shorter overall survival in primary esophageal squamous cell cancer cell, and AGK expression is significantly correlated with JAK2/STAT3 hyperactivation in esophageal squamous cell cancer cell, as well as in lung and breast cancer. Overexpression of AGK leads to activation of EGF receptor and promotes the proliferation and migration of prostate cancer cells, suggesting that AGK might act as a potent oncogene. AGK enhances JAK2 activity by blocking JH2-mediated autoinhibition of JAK2. Solid tumor cells override the autoinhibitory effect of JH2 to maintain activation of JAK2/STAT3 signaling, mechanism, overview. Enzyme AGK is a JH2 domain-interacting protein that activates the JAK2/STAT3 pathway Homo sapiens